Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q2 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.